GlassScriptPhysician profile
Geraldin Romis
NPI 1053819961
$3,930.03
in general payments reported to CMS, 2019-2025
19 companies · $1,610 in 2025
The $1,610 reported for 2025 was more than what 91% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $333 · 2022: $88.52 · 2023: $670 · 2024: $1,229 · 2025: $1,610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,170 · Education: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,169.79 |
| Education | $338.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $978.36 | 2021-2025 | Dupixent |
| Genzyme Corporation | $348.39 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $315.83 | 2021-2025 | |
| Incyte Corporation | $294.20 | 2024-2025 | Opzelura, Opzelura |
| Abbvie INC. | $291.62 | 2021-2025 | |
| Lilly USA, LLC | $272.07 | 2021-2025 | Taltz, Ebglyss, Olumiant |
| Janssen Biotech, INC. | $262.53 | 2024-2025 | Tremfya |
| Galderma Laboratories, L.P. | $220.16 | 2024-2025 | Nemluvio |
| Dermavant Sciences, INC. | $192.29 | 2023-2024 | Vtama |
| Leo Pharma INC. | $159.31 | 2022-2025 | Adbry |
| Sun Pharmaceutical Industries INC. | $147.55 | 2023-2024 | Winlevi, Absorica Ld |
| Organon LLC | $130.76 | 2025 | Vtama, Nexplanon |
| Pfizer INC. | $83.10 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $72.00 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $58.98 | 2022-2023 | Sotyktu |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $31.33 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.15 | 2025 | Spevigo |
| Arcutis Biotherapeutics, INC. | $23.41 | 2024 | Zoryve |
| Ani Pharmaceuticals, INC. | $21.99 | 2025 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geraldin Romis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.